Critical

Biological incident / bioterrorism (anthrax, plague, botulism)

high-consequence pathogen · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Deliberate or natural release of high-consequence pathogens presenting as clusters of severe illness. Early recognition of syndromic patterns, isolation, specific antimicrobials/antitoxin, and public health notification are critical to limit mortality and spread.

Red flags

  • Cluster of unexplained severe illness or deaths
  • Widened mediastinum on chest X-ray (inhalational anthrax)
  • Fulminant pneumonia with haemoptysis (pneumonic plague)
  • Symmetrical descending flaccid paralysis with clear sensorium (botulism)
  • Rapid clinical deterioration

Assessment

Differential diagnosis

  • Inhalational anthrax (widened mediastinum, haemorrhagic mediastinitis)
  • Pneumonic plague (fulminant pneumonia, haemoptysis)
  • Botulism (descending flaccid paralysis)
  • Tularaemia
  • Viral haemorrhagic fever
  • Severe community-acquired pneumonia/sepsis

Investigations

  • Blood cultures and specific microbiology (notify the lab of the suspected agent)
  • Chest imaging (widened mediastinum in anthrax; pneumonia in plague)
  • Lactate and sepsis workup
  • Nerve conduction/clinical assessment for botulism
  • Public health reference laboratory confirmation
  • Epidemiological clustering assessment

Management

  • Recognise the pattern: an unusual cluster of severe illness, rapidly progressive pneumonia, or descending paralysis suggests a deliberate release
  • Institute appropriate isolation and PPE (e.g. droplet/respiratory precautions for pneumonic plague)
  • Notify public health, the laboratory, and incident command immediately, and alert the reference lab before handling samples
  • Resuscitate for sepsis/septic shock with fluids, early antimicrobials, and vasopressors as needed
  • For anthrax, start combination therapy (e.g. ciprofloxacin plus a protein-synthesis inhibitor) and add antitoxin for systemic disease
  • For plague, give an aminoglycoside (gentamicin) or a fluoroquinolone and isolate pneumonic cases
  • For botulism, give botulinum antitoxin early and support ventilation for respiratory failure (do not wait for confirmation)
  • Secure the airway and provide ventilatory support for paralysis or respiratory compromise
  • Initiate post-exposure prophylaxis and contact tracing with public health for transmissible agents
  • Collect and preserve samples per forensic and public health protocols for a deliberate event
  • Provide supportive critical care and treat complications
  • Coordinate the mass-casualty and prophylaxis response with public health and emergency planning

Drugs & doses

Anthrax: ciprofloxacin 400 mg IV 12-hourly plus clindamycin/linezolid, add anthrax antitoxin (raxibacumab/obiltoxaximab)
Plague: gentamicin 5 mg/kg IV daily or ciprofloxacin 400 mg IV 12-hourly
Botulism: botulinum antitoxin (heptavalent) early per public health
Noradrenaline 0.05-0.5 mcg/kg/min for septic shock

Disposition

ICU with isolation as indicated; immediate public health notification and reference laboratory confirmation; coordinated prophylaxis, contact tracing, and surge response.

Complications & pitfalls

  • Septic shock and multi-organ failure
  • Respiratory failure (paralysis or pneumonia)
  • Haemorrhagic mediastinitis/meningitis (anthrax)
  • Secondary person-to-person transmission (pneumonic plague)
  • Overwhelmed healthcare capacity

Exam pearls

  • Think deliberate release when the epidemiology is unusual: wrong season, wrong host, tight clustering, or rapidly fatal pneumonia
  • Give botulism antitoxin on clinical suspicion, before laboratory confirmation, to halt progression
  • Alert the laboratory before sending samples so staff can take protective precautions
  • Early public health notification drives prophylaxis, isolation, and the wider response

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.